Drugs / LAENNEC (Human Placenta Hydrolysate)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05532124 | Jun 2021 → May 2023 | liver disorder | Green Cross Wellbeing | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LAENNEC (Human Placenta Hydrolysate) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05532124 ↗ |
| Route | Intravenous | “Intravenous Injection” NCT05532124 ↗ |